Last week, I joined dozens of other Rhode Islanders who have been touched by cancer – patients, survivors, caregivers, and those who have lost loved ones to the disease at the Statehouse for the American Cancer Society Cancer Action Network’s annual “Cancer Action Day.”

I had the chance to talk with lawmakers about a cost issue facing cancer patients today: to help afford the cost of their prescription drugs, many Rhode Islanders with cancer and other chronic disease take advantage of copay assistance offered through pharmaceutical manufacturers and other patient assistance programs. Unfortunately, recent changes to insurance industry practices – called “copay accumulator programs” threaten the positive impact of these programs.

(0) comments

Welcome to the discussion.

We’ve recently revised our comment policy to help us be more consistent and to be in keeping with our goal to promote a better community conversation. If a comment is deleted, rather than complain about it, simply try again by modifying the verbiage.

Comments that will be deleted include:
  • Those that include threatening, derogatory, obscene, vulgar, lewd, racist, sexist or sexually-oriented language. This includes any name-calling/nicknames of people both on the local and national level.
  • Those with accusations or allegations that can’t be proven, or that try to build a negative narrative about one person or entity over time through a clearly coordinated campaign. If you believe the backstory really needs to be shared, send us a letter to the editor or a story pitch with your name and contact information.
  • Those with outright lies or falsehoods.
Please use the 'Report' link on each comment to let us know if you believe a comment was allowed in error.

What we at The Breeze would truly like to see are comments that add history and context to a story or that use criticism constructively.